The Patient-Derived Xenograft Models market was valued at approximately USD 610 million in 2024 and is projected to reach around USD 1.45 billion by 2032, registering a healthy CAGR of 11.2% over the forecast period from 2025 to 2032.
Patient-Derived Xenograft Models Market Set for Robust Growth Driven by Precision Oncology Advances